NCT04471441 - Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

September 13, 2022

Study Completion Date

November 17, 2022

Conditions

Liver Transplant

Interventions

DRUG

Everolimus Tab.

After first dose 1mg BID(total 2mg daily PO), check the blood concentration of everolimus at each visit and adjust the dose to acheive the blood concentration maintaining at 3\~8ng/mL.

DRUG

Mycophenolate mofetil Tab./Cap.

Up to 1.5g BID(total 3g daily), PO

Trial Locations (1)

Unknown

RECRUITING

Severance Hospital, Seoul